Close
Find your Coloplast country website

Executive Leadership Team

Kristian Villumsen

Kristian Villumsen

President & CEO About Kristian Villumsen
Close

Kristian Villumsen

Download high resolution picture

President & CEO

Born: 1970

Nationality: Danish

No. of shares in Coloplast101,287 B shares

With Coloplast since: 2008

Previous responsibilities in Coloplast:
- Senior Vice President, Global Marketing and Commercial Excellence
- Senior Vice President, Region Europe
- Senior Vice President, Emerging Markets
- Executive Vice President, Chronic Care

Other board and management positions:
- Demant A/S: Board member and member of the audit committee

Kristian Villumsen holds a MA in Political Science from Aarhus University and a MA in Public Policy from Harvard University

Close
Anders Lonning-Skovgaard

Anders Lonning-Skovgaard

Executive Vice President, CFO About Anders Lonning-Skovgaard
Close

Anders Lonning-Skovgaard

Download high resolution picture

Executive Vice President, CFO

Born: 1972

Nationality: Danish

No. of  shares in Coloplast: 2,649 B shares

With Coloplast since: 2006

Previous responsibilities in Coloplast:
- Chief Business Controller, Ostomy Care
- Director Performance Management
- Chief Information Officer

Anders Lonning-Skovgaard is responsible for IT, Finance, Legal, Business Ethics, Intellectual property, Coloplast Business Centre in Poland and Investor Relations

Anders Lonning-Skovgaard holds a MSc in Finance and Accounting from Aarhus University

Close
Nicolai Buhl Andersen

Nicolai Buhl Andersen

Executive Vice President, Innovation About Nicolai Buhl Andersen
Close

Nicolai Buhl Andersen

Download high resolution picture

Executive Vice President, Innovation

Born: 1969 

Nationality: Danish

No. of shares in Coloplast: 0

With Coloplast since: 2005

Previous responsibilities in Coloplast:
- Senior Vice President, Commercial Development & Ostomy Care
- Vice President & General Manager, Sales Nordic Region
- Senior Vice President, Global Wound Care

Nicolai Buhl Andersen holds a MA in Economics & Business from Copenhagen Business School and Sophia University in Japan

Close
Paul Marcun

Paul Marcun

Executive Vice President, Growth About Paul Marcun
Close

Paul Marcun

Download high resolution picture

Executive Vice President, Growth

Born: 1966

Nationality: Australian

No. of shares in Coloplast: 0

With Coloplast since: 2015

Previous responsibilities in Coloplast:
- Senior Vice President, Emerging Markets
- Executive Vice President, Chronic Care

Paul Marcun holds a MBA in Corporate Finance & Marketing from Sydney University of Technology

Close
Dorthe Rønnau

Dorthe Rønnau

Senior Vice President, People & Culture About Dorthe Rønnau
Close

Dorthe Rønnau

Download high resolution picture

Senior Vice President, People & Culture

Born: 1966

Nationality: Danish

No. of shares in Coloplast535 B shares

With Coloplast since: 1996-2014, & 2022

Previous responsibilities in Coloplast:
- Operations Manager and Director, Wound Care
- Vice President , Global Quality & Business Improvement
- Vice President Danish production sites
- HR Director

Dorthe holds a Msc. In Industrial engineering, from Copenhagen University college of Engineering, a Msc. Psychology in Oranisations (MPO), from Roskilde University and a Graduate diploma in Business Administration

Close
Allan Rasmussen

Allan Rasmussen

Executive Vice President, Global Operations About Allan Rasmussen
Close

Allan Rasmussen

Download high resolution picture

Executive Vice President, Global Operations

Born: 1967

Nationality: Danish

No. of shares in Coloplast310 B shares

With Coloplast since: 1992

Previous responsibilities in Coloplast:
- Mechanical engineer
- Production Centre Manager
- Plant Manager
- Site Director
- General Manager
- Director, Volume Production
- Vice President, Corporate Procurement
- Senior Vice President, Global Operations

Other board and management positions:
- Ferrosan Medical Devices A/S: Board member

Allan Rasmussen holds a BPSE, IMD, E*MBA from Scandinavian International Management Institute, and a BSc (Mech. Eng.), from Technical University of Denmark

Close

Board of Directors

Lars Rasmussen

Lars Rasmussen

Chairman of the Coloplast Board About Lars Rasmussen
Close

Lars Rasmussen

Download high resolution picture

Chairman

Born: 1959

Nationality: Danish

No. of shares in Coloplast: 12,100 B-shares

Joined the board in 2018

Chairman of the Remuneration and Nomination Committee
Member of the Audit Committee

Other board and management positions:

- H. Lundbeck A/S: Chairman of the Board, chairman of the remuneration and nomination committee and member of the audit committee
WSAudiology A/S: Chairman of the Board 
- Chairman of the Danish Committee on Corporate Governance
- Chairman of the Life Science Council established by the Danish Government
- Limacorporte SpA: Chairman of the Board
- Gyldendal A/S: Board member

Lars Rasmussen acted as Coloplast’s President & CEO from 2008 – 2018 and was a member of Coloplast’s executive management from 2001 - 2018. Lars Rasmussen has extensive executive management and board experience from international listed companies in the med-tech and pharma industry. Lars Rasmussen possesses in-dept knowledge within commercialisation of innovation, B2B and B2C sales models and efficiency improvements.

Lars Rasmussen holds a Bachelor of Science degree in Engineering from Aalborg University and an Executive MBA from SIMI.

Lars Rasmussen is not considered independent.

Close
Niels Peter Louis-Hansen

Niels Peter Louis-Hansen

Deputy Chairman of the Coloplast Board About Niels Peter Louis-Hansen
Close

Niels Peter Louis-Hansen

Download high resolution picture

Deputy Chairman

Born: 1947

Nationality: Danish

No. of shares in Coloplast:
- Coloplast Holding ApS (controlled by Niels Peter Louis-Hansen): 14,791,000 A shares and 52,511,517 B shares
- N.P. Louis-Hansen ApS: 1.180.550 B-shares
- Niels Peter Louis-Hansen's personal holding: 1,094,000 A shares and 2,106,000 B shares

Joined the board in 1968

Member of the Remuneration and Nomination Committee

Other board and management positions:
- Aage og Johanne Louis-Hansens Fond: Chairman of the Board
- Aage og Johanne Louis-Hansen A/S: Chairman of the Board
- N.P. Louis-Hansen ApS: CEO
- NPLH Anpartsinvest ApS: CEO
- NPLH Property Investments ApS: CEO

Through decades of board work, Niels Peter Louis-Hansen has gained in-dept knowledge of the industries in which Coloplast operates, its dynamics and key players as well as deep insight into strategy development. Furthermore, Niels Peter Louis-Hansen is a key contributor to preserving the Coloplast-culture.

Niels Peter Louis-Hansen holds a degree as Civiløkonom.

Niels Peter Louis-Hansen is not considered independent.

Close
Carsten Hellmann

Carsten Hellmann

Member of the Coloplast Board About Carsten Hellmann
Close

Carsten Hellmann

Download high resolution picture

Board Member

Born: 1964

Nationality: Danish

No. of shares in Coloplast6,000 B shares

Joined the board in 2017

Member of the Audit Committee

Other board and management positions:
- Chanelle Pharma: Chairman
- The Danish Chamber of Commerce: Board member

Carsten Hellmann has considerable executive management experience. From 2016-2023 Carsten Hellmann was the President & CEO in ALK-Abelló A/S, a listed pharmaceutical company. Prior to that, Carsten Hellmann held several top management and CEO positions in the Health Care industry, as CEO of Merial in France and member of the Executive Committee of the French pharmaceutical company Sanofi. Carsten Hellmann has extensive experience in product development and international commercialization within highly regulated industries as well as M&A activities, including post integration.

Carsten Hellmann holds a BSc in Business Administration from Copenhagen Business School and a MSc in Information Management from Lancaster University.

Carsten Hellmann is considered independent.

Close
Annette Brüls

Annette Brüls

Member of the Coloplast Board About Annette Brüls
Close

Annette Brüls

Download high resolution picture

Board Member

Born: 1971

Nationality: Belgian

No. of shares in Coloplast: 0

Joined the board in 2021

Member of the Remuneration and Nomination Committee

Other board and management positions:
- Edwards Lifesciences, Corporate Vice President, EMEACLA.

Annette Brüls has considerable executive management experience within global medical device businesses. From 2018-2024 Annette was the CEO of Medela AG, one of the world’s leading providers of breastfeeding products and medical vacuum technology. Prior to that, Annette Brüls spent 11 years with Medtronic holding several senior leadership positions in both Europe and the US. Annette Brüls has in-depth knowledge and understanding of product development and commercialization within the med-tech industry and in particular in chronic disease management, including digital services and value-based healthcare models.

Annette Brüls has an engineering degree in medical and electronic engineering from the University of Liège in Belgium.

Annette Brüls is considered independent.

Close
Jette Nygaard-Andersen

Jette Nygaard-Andersen

Member of the Coloplast Board About Jette Nygaard-Andersen
Close

Jette Nygaard-Andersen

Download high resolution picture

Board Member

Born: 1968

Nationality: Danish

No. of shares in Coloplast: 0

Joined the board in 2015

Member of the Remuneration and Nomination Committee

Other board and management positions:
Jette Nygaard-Andersen has held numerous international management positions. Most recently, Jette Nygaard-Andersen was acting as CEO and Executive Director in Entain plc. Jette Nygaard-Andersen has considerable executive management and board experience within global med-tech, media & entertainment, and digital growth businesses. Jette Nygaard-Andersen has extensive experience within business and marketing strategies, digital transformation, optimization of customer experience and customer engagement, working with digital growth start-ups globally and M&A activities, including post integration.

Jette Nygaard-Andersen holds a MSc in Business, Finance & Economics from the University of Copenhagen and Executive Development Programs from INSEAD and Executive Leadership Programmes from Columbia University.

Jette Nygaard-Andersen is considered independent.

Close
Marianne Wiinholt

Marianne Wiinholt

Member of the Coloplast Board About Marianne Wiinholt
Close

Marianne Wiinholt

Download high resolution picture

Board Member

Born: 1965

Nationality: Norwegian

No. of shares in Coloplast: 500 B shares

Joined the board in 2020

Chairman of the Audit Committee

Other board and management positions:
- Norsk Hydro ASA (BM) and chairman of the audit committee
- WS Audiology A/S, CFO

Marianne Wiinholt has considerable executive management experience. From April 2022, Marianne Wiinholt has acted as CFO in WS Audiology A/S which was formed in 2019 through the merger of Sivontos and Widex. Previously, Marianne Wiinholt acted as CFO in Ørsted A/S, a listed company in the energy sector. Prior to becoming CFO in Ørsted A/S, Marianne Wiinholt held several management positions in Ørsted A/S. Marianne Wiinholt has extensive experience within finance and accounting and considerable knowledge and experience in leading, driving and delivering a sustainability agenda on a global scale.

Marianne Wiinholt holds a MSc in Business Administration and Auditing and is qualified State Authorised Public Accountant.

Marianne Wiinholt is considered independent.

Close
Thomas Barfod

Thomas Barfod

Senior Controller and member of the Coloplast Board About Thomas Barfod
Close

Thomas Barfod

Download high resolution picture

Senior Controller and Board Member

Born: 1970

Nationality: Danish

No. of shares in Coloplast: 0

Joined the board in 2006

With Coloplast since: 1992

Board responsibility at Coloplast:
Member of the Board elected by the employees

Latest re-election: 
December 2018

This Board member is not considered to be independent

Educational background:
Basic Vocational Education
Commercial training

Close
Nikolaj Kyhe Gundersen

Nikolaj Kyhe Gundersen

Skilled Precision Engineer, Project Management & Prototyping, and member of the Coloplast Board About Nikolaj Kyhe Gundersen
Close

Nikolaj Kyhe Gundersen

Download high resolution picture

Skilled Precision Engineer, Project Management & Prototyping, and Board Member

Born: 1969

Nationality: Danish

No. of shares in Coloplast: 0

Joined the board in 2018

With Coloplast since: 1992

Board responsibility at Coloplast:
Member of the Board elected by the employees

This Board member is not considered to be independent

Educational background:
Skilled precision engineer

Close
Roland Vendelbo Pedersen

Roland Vendelbo Pedersen

Lead Negotiator, Corporate Procurement, and member of the Coloplast Board About Roland Vendelbo Pedersen
Close

Roland Vendelbo Pedersen

Download high resolution picture

Lead Negotiator, Corporate Procurement, and Board Member

Born:1962

Nationality: Danish

No. of shares in Coloplast1,622 B shares

Joined the board in 2018

With Coloplast since: 1998

Board responsibility at Coloplast:
Member of the Board elected by the employees

This Board member is not considered to be independent

Educational background:
This information to follow

Close

Board evaluation – annual self-assessment (FY 2022/23)


Every year, the Board of Directors conducts a self-assessment. Based on the result of this assessment, the organisation and efficiency of the Board of Directors' work are discussed at a Board meeting. In 2023, the annual self-assessment of the Board of Directors was performed partly with external assistance. The self-assessment consisted of five qualitative questions addressing certain strategic topics in which board members as well as the Executive Leadership Team responded anonymously.

The self-assessment shows that there is an open and transparent dialogue between the Board of Directors and the Executive Leadership Team, and the board committees serve as good vehicles for framing the discussions in the Board of Directors and ensure that key risks are addressed.

Furthermore, the self-assessment shows that the composition of the Board of Directors, including relevant competencies, to a large extent matches what the Board of Directors considers necessary to best perform its tasks, such as finance, digital transformation, customer experience, commercialisation, sustainability, industry knowledge incl. the US market, general management, innovation, legal affairs and acquisitions. However, with the acquisition of Kerecis hf., the board would like to strengthen its competences within the biologics space.

During the past year, the Board of Directors has spent time monitoring and discussing the progress made on Coloplast’s Strive25 strategy as well as the company’s acquisition of Kerecis hf.. Furthermore, the Board of Directors has spent a significant amount of time discussing and addressing challenges caused by current world events. Further, the board strategy days were held in Hungary where the board conducted a deep dive of Global Operations.

View desktop version